Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Peters

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Clinical and Translational Radiation Oncology|February 3, 2021
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear acceleratorThomas Willigenburg, Daan M de Muinck Keizer, Max Peters, et al.
World Journal of Urology|August 21, 2012
Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature reviewMax Peters, Maaike R Moman, Henk G van der Poel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone MetastasesJoanne M van der Velden, Max Peters, Jorrit-Jan Verlaan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2014
Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of lifeMax Peters, Metha Maenhout, Jochem R N van der Voort van Zyp, et al.
Acta Oncologica (Stockholm, Sweden)|March 17, 2023
Feasibility and first results of the 'Trials-within-Cohorts' (TwiCs) design in patients undergoing radiotherapy for lung cancerMathijs L Tomassen, Pim J J Damen, Helena M Verkooijen, et al.
Practical Radiation Oncology|August 2, 2019
Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment NomogramPeter S N van Rossum, Wei Deng, David M Routman, et al.
Brachytherapy|November 29, 2015
Rectal dose constraints for salvage iodine-125 prostate brachytherapyMax Peters, Carel J Hoekstra, Jochem R N van der Voort van Zyp, et al.
Annals of Surgical Oncology|October 31, 2021
Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?W Hugo van Joolingen, Marnix J A Rasing, Max Peters, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2020
MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localized Radiorecurrent Prostate Cancer: Updated Results of 50 PatientsMarieke Juliet van Son, Max Peters, Marinus A Moerland, et al.
Cancers|February 15, 2022
Value of Targeted Biopsies and Combined PSMA PET/CT and mp-MRI Imaging in Locally Recurrent Prostate Cancer after Primary RadiotherapyMarnix Rasing, Marieke van Son, Marinus Moerland, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Clinical and Translational Radiation Oncology|February 3, 2021
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear acceleratorThomas Willigenburg, Daan M de Muinck Keizer, Max Peters, et al.
World Journal of Urology|August 21, 2012
Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature reviewMax Peters, Maaike R Moman, Henk G van der Poel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2017
Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone MetastasesJoanne M van der Velden, Max Peters, Jorrit-Jan Verlaan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2014
Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of lifeMax Peters, Metha Maenhout, Jochem R N van der Voort van Zyp, et al.
Acta Oncologica (Stockholm, Sweden)|March 17, 2023
Feasibility and first results of the 'Trials-within-Cohorts' (TwiCs) design in patients undergoing radiotherapy for lung cancerMathijs L Tomassen, Pim J J Damen, Helena M Verkooijen, et al.
Practical Radiation Oncology|August 2, 2019
Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment NomogramPeter S N van Rossum, Wei Deng, David M Routman, et al.
Brachytherapy|November 29, 2015
Rectal dose constraints for salvage iodine-125 prostate brachytherapyMax Peters, Carel J Hoekstra, Jochem R N van der Voort van Zyp, et al.
Annals of Surgical Oncology|October 31, 2021
Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?W Hugo van Joolingen, Marnix J A Rasing, Max Peters, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2020
MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localized Radiorecurrent Prostate Cancer: Updated Results of 50 PatientsMarieke Juliet van Son, Max Peters, Marinus A Moerland, et al.
Cancers|February 15, 2022
Value of Targeted Biopsies and Combined PSMA PET/CT and mp-MRI Imaging in Locally Recurrent Prostate Cancer after Primary RadiotherapyMarnix Rasing, Marieke van Son, Marinus Moerland, et al.
Pageof 10